ESC 365 - Navigating the disease course in hereditary ATTR amyloidosis

Open Access

Navigating the disease course in hereditary ATTR amyloidosis

Event: Heart Failure 2021 Online Congress

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Sponsored by Alnylam Pharmaceuticals

Date: 29 June 2021

Time: 11:40 - 12:25

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction.

Speaker: Doctor N. Fine (Calgary, CA)

Detecting hereditary ATTR amyloidosis: From cardiac complications to multisystem manifestations.

Speaker: Doctor N. Fine (Calgary, CA)

Tracing the origins and treating progression in hereditary ATTR amyloidosis with polyneuropathy.

Speaker: Professor M. Fontana (London, GB)

Time for change: Why early intervention matters.

Speaker: Professor A. Yilmaz (Muenster, DE)

Panel discussion and meeting close.

4 speakers from this session

Doctor Nowell Fine

, Calgary (Canada)

2 presentations

0 follower

Doctor Nowell Fine

, Calgary (Canada)

2 presentations

0 follower

Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

15 presentations

10 followers

Professor Ali Yilmaz

University Hospital Munster - UKM, Muenster (Germany)

3 presentations

0 follower

This platform is supported by